Our study not only enriches the IL12RB1 mutation database, but also provides patients with a more accurate diagnosis as well as precise treatment choices of Chinese MSMD patients. This evidence concerns the gene IL12RB1 and Mendelian susceptibility to mycobacterial diseases.